V A L I D A T E - Validation of a Trustworthy AI-based Clinical Decision Suppor...
V A L I D A T E - Validation of a Trustworthy AI-based Clinical Decision Support System for Improving Patient Outcome in Acute Stroke Treatment
Based on previously developed models and an existing prototype of a clinical decision support system (patent pending), we set out in this project to further develop, test, and validate this clinical decision support for the treatm...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
iTrust
In time TReatment of acUte ischaemic STroke
3M€
Cerrado
iTRUST
iTRUST In time TReatment of acUte ischaemic STroke
71K€
Cerrado
DECIMAL
DETECTION OF CEREBRAL ISCHEMIA BASED ON MACHINE LEARNING
138K€
Cerrado
TreatStroke
arTificial neuRal nEtwork prediction of hAemorrhagic Transfo...
114K€
Cerrado
AISN
Integrating AI in Stroke Neurorehabilitation
6M€
Cerrado
ERYTHROAG
A new ICT based device RHEO 01 for fast point of care anal...
71K€
Cerrado
Información proyecto VALIDATE
Duración del proyecto: 47 meses
Fecha Inicio: 2022-05-01
Fecha Fin: 2026-04-30
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Based on previously developed models and an existing prototype of a clinical decision support system (patent pending), we set out in this project to further develop, test, and validate this clinical decision support for the treatment stratification of acute stroke patients to improve patient outcome. Machine learning (ML)-enabled Artificial intelligence (AI) methods are increasingly adopted in the medical field. Implementing ML-based CDSSs have the potential to be go beyond the current clinical state-of-the-art as AI excels at finding complex and non-linear relationships across a multitude of prognostic variables. AI also has the promise to combine different modalities, such as imaging and clinical values, leading to powerful stratification tools accounting for a multitude of patient sub-populations. Our consortium combines excellence in technical and medical machine learning development with the clinical expertise of three leading stroke hospital partners. Additionally, our consortium benefits from the special expertise in the development of trustworthy AI, software design, and the translation of AI models to the clinical setting with focus on the regulatory process. By leveraging the available medical data and exploiting technological opportunities in the field of AI, and developing and validating trustworthy AI solutions to be implemented in the clinical workflow we are seeking to surpass the clinical state-of-the-art by making a significant and sustainable impact on the treatment of acute stroke that will improve patient survival, outcome and quality of life. The results of our work will serve as a pathway for future projects and we will make our experiences public in the form of standard operating procedures (SOPs) in the areas of development, testing, validation, and regulatory processes.